Sinovac Vaccine Falls Short of Expectations, But Options Limited

"Better than nothing." 

That's one infectious disease expert's assessment of Sinovac Biotech's COVID-19 vaccine, following reports that hundreds of Indonesian health care workers who had received the vaccine caught the disease anyway.   Sorry, but your browser cannot support embedded video of this type, you can download this video to view it offline. At least 10 doctors have died after getting both doses of Sinovac's CoronaVac vaccine, according to the Indonesian Medical Association.  It's unclear how widespread these "breakthrough" infections are. It's also not clear how severe most of the infections are. Little peer-reviewed data on the vaccine are available.